AU4315100A - Preventive or inhibitory agents for hepatopathy - Google Patents

Preventive or inhibitory agents for hepatopathy

Info

Publication number
AU4315100A
AU4315100A AU43151/00A AU4315100A AU4315100A AU 4315100 A AU4315100 A AU 4315100A AU 43151/00 A AU43151/00 A AU 43151/00A AU 4315100 A AU4315100 A AU 4315100A AU 4315100 A AU4315100 A AU 4315100A
Authority
AU
Australia
Prior art keywords
hepatopathy
preventive
inhibitory agents
inhibitory
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43151/00A
Inventor
Hiromi Doi
Tomio Kimura
Takaichi Shimozato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU4315100A publication Critical patent/AU4315100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
AU43151/00A 1999-04-28 2000-04-28 Preventive or inhibitory agents for hepatopathy Abandoned AU4315100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/120982 1999-04-28
JP12098299 1999-04-28
PCT/JP2000/002813 WO2000066124A1 (en) 1999-04-28 2000-04-28 Preventive or inhibitory agents for hepatopathy

Publications (1)

Publication Number Publication Date
AU4315100A true AU4315100A (en) 2000-11-17

Family

ID=14799863

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43151/00A Abandoned AU4315100A (en) 1999-04-28 2000-04-28 Preventive or inhibitory agents for hepatopathy

Country Status (2)

Country Link
AU (1) AU4315100A (en)
WO (1) WO2000066124A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122666B2 (en) 1999-07-21 2006-10-17 Sankyo Company, Limited Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
JP4722360B2 (en) * 1999-11-12 2011-07-13 メルク・シャープ・エンド・ドーム・コーポレイション Diarylpiperidylpyrrole derivatives as antiprotozoal agents
GB0028383D0 (en) 2000-11-21 2001-01-03 Novartis Ag Organic compounds
BR0206533A (en) * 2001-01-18 2003-12-16 Sankyo Co Compound, pharmaceutical composition, and use of a compound
WO2002057255A1 (en) * 2001-01-22 2002-07-25 Sankyo Company, Limited 4- or 5-substituted pyrrole derivatives
JP2005505562A (en) * 2001-09-05 2005-02-24 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー Pyridylfuran and pyrrole as Raf kinase inhibitors
WO2009035997A2 (en) * 2007-09-14 2009-03-19 Cara Therapeutics, Inc. Benzo-fused heterocycles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300141A (en) * 1992-01-13 1994-07-29 Smithkline Beecham Corp NOVEL IMIDAZOLE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
DE69433501T2 (en) * 1993-11-08 2004-11-04 Smithkline Beecham Corp. OXAZOLES FOR TREATING CYTOKINE MEDIATED DISEASES
CA2195847A1 (en) * 1994-07-27 1996-02-08 John J. Talley Substituted thiazoles for the treatment of inflammation
JPH11510511A (en) * 1995-08-10 1999-09-14 メルク エンド カンパニー インコーポレーテッド 2,5-Substituted arylpyrroles, compositions containing this compound and methods of use
JP3294616B2 (en) * 1995-08-10 2002-06-24 メルク エンド カンパニー インコーポレーテッド 2-Substituted arylpyrroles, compositions containing such compounds and methods of use
AU702887B2 (en) * 1995-10-31 1999-03-11 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
BR9710352A (en) * 1996-07-11 1999-08-17 Pfizer Pyridylpyrrole compounds
JPH11209377A (en) * 1997-11-14 1999-08-03 Sankyo Co Ltd Pyridylpyrrole derivative
JP2000080094A (en) * 1998-07-02 2000-03-21 Sankyo Co Ltd Five-membered heteroaryl compound

Also Published As

Publication number Publication date
WO2000066124A1 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
PT2270173E (en) Combination neisserial compositions
AU2951299A (en) Disinfecting compositions and processes for disinfecting surfaces
AU5100599A (en) Egf-genistein for prevention of restenosis
AU3979200A (en) Antimicrobial agents
AU1530001A (en) Inhibitor compositions
AU2608301A (en) Methods for inhibiting mastocytosis
AU1560200A (en) Disinfecting agents
AU2578200A (en) Jammer
AU2321000A (en) Fat accumulation inhibitory agents
AU3235100A (en) Prothease inhibitors
AU4315100A (en) Preventive or inhibitory agents for hepatopathy
AU7432698A (en) Disinfectant composition
AU143207S (en) Pantiliner
AU5085300A (en) Compositions
AU2939000A (en) Preventive or therapeutic agents for inflammatory dermatoses
AU6553998A (en) Methods for inhibiting bacterial cytotoxicity
AU4144000A (en) Compositions for treating brain infarction
AU5809400A (en) Fungicidal compositions
AU5704800A (en) Medicinal compositions for preventing or treating diarrhea
AU3778599A (en) Herbicidal compositions
AU6124399A (en) Herbicidal compositions
AUPQ316699A0 (en) Wrench
AU5216200A (en) Fungicidal compositions
AU6870900A (en) Herbicidal compositions
AU2028401A (en) 3-methyl-chromane or thiochromane derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase